Proteinase-Activated Receptor-2: Key Role of Amino-Terminal Dipeptide Residues of the Tethered Ligand for Receptor Activation

Molecular Pharmacology

Volumn 65, Issue 1, 2004, Pages 149-156

  Al Ani, Bahjat ^a,b   Hansen, Kristina K ^a   Hollenberg, Morley D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDE; LIGAND; PROTEINASE ACTIVATED RECEPTOR 2;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CELL TRANSFORMATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; KIDNEY CELL; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR UPREGULATION; RESIDUE ANALYSIS; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; CALCIUM SIGNALING; DIPEPTIDES; LIGANDS; RATS; RECEPTOR, PAR-2; SOLUBILITY; TRYPSIN;

EID: 1642576977     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.65.1.149     Document Type: Article

References (23)

1. Al-Ani B and Hollenberg MD (2003) Selective tryptic cleavage at the tethered ligand site of the amino terminal domain of proteinase-activated receptor-2 in intact cells. J Pharmacol Exp Ther 304:1120-1128.
2. 2 in rat vascular and gastric smooth muscle. Can J Physiol Pharmacol 73:1203-1207.
3. Al-Ani B, Saifeddine M, Kawabata A, and Hollenberg MD (1999a) Proteinase activated receptor 2: role of extracellular of loop 2 for ligand-mediated activation. Br J Pharmacol 128:1105-1113.
4. Al-Ani B, Saifeddine M, Kawabata A, Renaux B, Mokashi S, and Hollenberg MD (1999b) Proteinase-activated receptor-2 (PAR2): development of a ligand binding assay correlating with activation of PAR2 by PAR1 -and PAR2-derived peptide ligands. J Pharmacol Exp Ther 290:753-760.
5. Al-Ani B, Saifeddine M, Wijesuriya J, and Hollenberg MD (2002a) Modified proteinase activated-receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin. J Pharmacol Exp Ther 300:702-708.
6. Al-Ani B, Wijesuriya J, and Hollenberg MD (2002b) Proteinase-activated receptor-2: differential activation of the receptor by tethered ligand versus soluble peptide analogues. J Pharmacol Exp Ther 302:1046-1054.
7. Blackhart BD, Ruslim-Litrus L, Lu CC, Alves VL, Teng W, Scarborough RM, Reynolds EE, and Oksenberg D (2000) Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide. Mol Pharmacol 58:1178-1187.
8. Böhm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, Connolly A, Kahn M, Nelken NA, Coughlin SR, Payan DG, et al. (1996) Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 14:1009-1016.
9. Compton SJ, Cairns JA, Palmer KJ, Al-Ani B, Hollenberg MD, and Walls A (2000) A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists. J Biol Chem 275:39207-39212.
10. 2) by human mast cell tryptase. Br J Pharmacol 134:705-718.
11. Déry O, Corvera CU, Steinhoff M, and Bunnett NW (1998) Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 274:1429-1452.
12. Hollenberg MD and Compton SJ (2002) International Union of Pharmacology. XX-VIII. Proteinase-activated receptors. Pharmacol Rev 54:203-217.
13. Hollenberg MD, Saifeddine M, and Al-Ani B (1996) Proteinase-activated receptor-2 in rat aorta: Structural requirements for agonist activity of receptor-activating peptides. Mol Pharmacol 49:229-233.
14. Hollenberg MD, Saifeddine M, Al-Ani B, and Kawabata A (1997) Proteinase-activated receptors: structural requirement for activity, receptor cross-reactivity and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 75:832-841.
15. Kao JP, Harootunian AT, and Tsien RY (1989) Photochemically generated cytosolic calcium pulses and their detection by fluo-3. J Biol Chem 264:8179-8184.
16. Kawabata A, Saifeddine M, Al-Ani B, Leblond L, and Hollenberg MD (1999) Evaluation of proteinase-activated receptor-a (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands. J Pharmacol Exp Ther 288:358-370.
17. Kong W, McConalogue K, Khitin LM, Hollenberg MD, Payan DG, Böhm SK, and Bunnett NW (1997) Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc Natl Acad Sci USA 94:8884-8889.
18. Maryanoff BE, Santulli RJ, McComsey DF, Hoekstra WJ, Hoey K, Smith CE, Addo M, Darrow AL, and Andrade-Gordon P (2001). Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes. Arch Biochem Biophys 386(2):195-204.
19. Minta A, Kao JP, and Tsien RY (1989) Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J Biol Chem 264:8171-8178.
20. Nystedt S, Emilson K, Wahlestadt C, and Sundelin J (1994) Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91:9208-9212.
21. Saifeddine M, Al-Ani B, Cheng CH, Wang L, and Hollenberg MD (1996) Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol 118:521-530.
22. Sanger F, Nicklen S, and Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Nod Acad Sci USA 7:5463-5467.
23. Vu T-KH, Hung DT, Wheaton VI, and Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.